883541-93-3 Usage
Uses
Used in Pharmaceutical Industry:
6-Methyl-1H-benzoimidazole-2-carbaldehyde is used as a building block for the synthesis of various pharmaceuticals, contributing to the development of new drugs and therapeutic agents. Its unique chemical structure allows for the creation of a wide range of compounds with potential medicinal properties.
Used in Chemical Reactions:
As an intermediate in chemical reactions, 6-Methyl-1H-benzoimidazole-2-carbaldehyde facilitates the synthesis of complex organic compounds. Its presence in these reactions enables the formation of desired products, making it a valuable component in the process of organic synthesis.
Used in Research and Development:
6-Methyl-1H-benzoimidazole-2-carbaldehyde is utilized as a research compound for studying the properties and behaviors of different chemical structures. Its unique characteristics provide valuable insights into the field of organic chemistry, aiding in the understanding of molecular interactions and the development of novel synthetic pathways.
Check Digit Verification of cas no
The CAS Registry Mumber 883541-93-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,3,5,4 and 1 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 883541-93:
(8*8)+(7*8)+(6*3)+(5*5)+(4*4)+(3*1)+(2*9)+(1*3)=203
203 % 10 = 3
So 883541-93-3 is a valid CAS Registry Number.
883541-93-3Relevant articles and documents
PYRAZOLOPYRAZINES ACTING ON CANCERS VIA INHIBITION OF CDK12
-
Page/Page column 155, (2021/09/11)
The present invention provides compounds of general formula (I) in which X, R1, R2 and R3 are as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment and/or prophylaxis of diseases, in particular of hyperproliferative disorders such as cancer disorders, as a sole agent or in combination with other active ingredients.
One-Pot Base-Mediated Synthesis of Functionalized Aza-Fused Polycyclic Quinoline Derivatives
Jiang, Zeng-Qiang,Miao, Da-Zhuang,Tong, Yao,Pan, Qiang,Li, Xiao-Tong,Hu, Ren-He,Han, Shi-Qing
supporting information, p. 1913 - 1921 (2015/06/30)
A new one-pot protocol has been developed for the facile and efficient synthesis of aza-fused polycyclic quinolines (e.g., pyrrolo[1,2-a]quinolines) by the base-catalyzed reaction of 2-formylpyrroles and 2-halophenylacetonitriles. This reaction proceeded under transition metal-free conditions and showed high functional group tolerance, with the desired products being formed in good yields.
